Achaogen Announces Presentations at Two Investor Healthcare Conferences in November
November 09, 2018 08:01 ET
|
Achaogen, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents...
Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
November 09, 2018 08:01 ET
|
Celldex Therapeutics, Inc.
--Well tolerated; dose dependent biological effects consistent with CD40-mediated immune cell activity----Program development expanded based on results observed to date-- HAMPTON, N.J., Nov. 09,...
Atea Pharmaceuticals to Present Positive Clinical Data with At-527 for the Treatment of Chronic Hepatitis C in Patients with Cirrhosis at The Liver Meeting ® 2018
November 09, 2018 08:01 ET
|
Atea Pharmaceuticals, Inc.
AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor AT-527 shows profound and equivalent pan-genotypic antiviral activity in cirrhotic and non-cirrhotic (NC) hepatitis...
CPP Fund Totals $368.3 Billion at Second Quarter Fiscal 2019
November 09, 2018 08:00 ET
|
CPP Investment Board
CPPIB advances preparations to accept, invest and manage the Additional Canada Pension Plan contributions in January 2019 All figures in Canadian dollars unless otherwise noted. TORONTO, Nov. 09,...
Citrus Fiber Valued at US$ 92 Million in 2018, Bakery Industry Driving Growth
November 09, 2018 08:00 ET
|
FACT.MR
Rockville, MD, Nov. 09, 2018 (GLOBE NEWSWIRE) -- A new Fact.MR study on citrus fiber market finds that the market grew at a healthy 4.3% y-o-y over 2017 to surpass US$ 92 million by the end of 2018....
REPEAT - Wayland Group Announces Definitive Agreement for Italian Joint Venture
November 09, 2018 08:00 ET
|
Wayland Group
TORONTO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it has completed a definitive joint venture...
Scholar Rock Demonstrates that Highly Specific TGFβ1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy
November 09, 2018 08:00 ET
|
Scholar Rock
Preclinical Data Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting Shows Highly Specific Inhibitor of TGFβ1, SRTβ1-Ab3, Renders Resistant Solid Tumors Vulnerable to PD1...
Nuance Announces Corporate Governance Enhancement by Adopting Provision for Shareholders to Call Special Meeting
November 09, 2018 08:00 ET
|
Nuance Communications, Inc.
BURLINGTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Nuance Communications, Inc. (NASDAQ: NUAN) today announced that its Board of Directors has adopted amendments to the Company’s Bylaws that allow...
Spring Bank Announces Additional Inarigivir Results at AASLD Conference
November 09, 2018 08:00 ET
|
Spring Bank Pharmaceuticals, Inc.
*Results from full 24 weeks of dosing from the first three cohorts of the ongoing Phase 2 ACHIEVE trial in hepatitis B to be highlighted *New data from ACHIEVE trial demonstrates that increased...
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
November 09, 2018 08:00 ET
|
Rhythm Pharmaceuticals, Inc.
-- Presented Updated Data from Phase 2 Basket Studies in Bardet-Biedl Syndrome (BBS) and Alström Syndrome at the 57th Annual European Society for Pediatric Endocrinology (ESPE) Meeting -- -- Launched...
- May 25, 2024 09:40 ET Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
- May 24, 2024 20:18 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB)